lentiviral-crisprcas9-mediated-genome-editing-for-study-hematopoietic

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Manipulating genes in hematopoietic stem cells using conventional transgenesis approaches can be time-consuming, expensive, and challenging. Benefiting ...

University of Virginia School of Medicine

Clonal hematopoiesis has been associated with increased mortality and cardiovascular disease. This condition can arise from somatic mutations in preleukemic driver genes within hematopoietic stem/progenitor cells. Approximately 40 candidate driver genes have been identified, but mutations in only 1 of these genes, TET2 (ten-eleven translocation-2), has been shown to casually contribute to cardiovascular disease in murine models.

CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.

Although the complex roles of macrophages in myocardial injury are widely appreciated, the function of neutrophils in nonischemic cardiac pathology has received relatively little attention.

Miho Sano

Hematovascular Biology Center,
Robert M. Berne Cardiovascular Research Center,
Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center

University of Virginia School of Medicine

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Miho Sano

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Hematovascular Biology Center,Robert M. Berne Cardiovascular Research Center,Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center

University of Virginia School of Medicine

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Hematovascular Biology Center,
Robert M. Berne Cardiovascular Research Center,
Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center